MedTrace Logo

Białystok PLUS - Polish Longitudinal University Study

NCT03197363 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2023-03-15

No results posted yet for this study

Summary

The main goal of the study is to provide a unique multidimensional picture of the health of the population with simultaneous optimal standards of sampling, processing and storing of data and biomaterial that will allow discovering novel mechanisms in the development and progression of common civilization diseases. In the effect it will improve prevention, diagnosis and treatment.

Conditions

Interventions

OTHER

Discovering novel risk factors.

The study protocol includes multiple imaging and functional investigations (including heart, carotid, thyroid, liver ultrasound, fundoscopy, plethysmography, pulse wave velocity, ankle-brachial index, ECG, body composition measured by bioimpedance and dual energy x-ray absorptiometry, anthropometric assessment, rhinometry, hand grip test, oral glucose tolerance test, advance glycation end-products measurement, voice recording. There will be a detailed and verified questionnaires concerning various activities of the subject: physical activity, depression, sino-nasal symptoms, prostate hypertrophy, female urinary tract symptoms, quality of life, smoking and drinking addiction, hirsutism.

Sponsors & Collaborators

  • University Medicine Greifswald

    collaborator OTHER

  • City of Białystok

    collaborator UNKNOWN

  • Marshall's Office of Podlaskie Voivodship

    collaborator UNKNOWN

  • Medical University of Bialystok

    lead OTHER

Principal Investigators

  • Karol A. Kaminski, Professor · Medical University of Bialystok

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-05
Primary Completion
2024-12-31
Completion
2029-12-31

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03197363 on ClinicalTrials.gov